Bafna Pharma adds two fully automated packaging lines to existing capacity; Stock hits 5% upper circuit

The packaging lines have received approval from the UK-MHRA (Medicines and Healthcare products Regulatory Agency) for the United Kingdom and the European Union (EU).

May 04, 2021 12:05 IST India Infoline News Service

Bafna Pharmaceuticals has added two fully automated packaging lines to its existing capacity. The following has been approved by the UK-MHRA (Medicines and Healthcare products Regulatory Agency) for the United Kingdom and the European Union (EU).

Mahaveer Chand Bafna, CEO of Bafna Pharmaceuticals Ltd. says, "The approval from UK- MHRA will provide further momentum to our already expanding business in the UK, Europe and other Regulated Markets. This approval will enable Bafna Pharma to increase its output and consequentially generate higher revenue and profits."

At around 12.17 pm, Bafna Pharma was trading at the upper circuit limit of Rs135.15  per piece up by 4.97% on Sensex. 

Related Story

Open Free Demat Account (Rs699)